latest blog entries
Loading...
Branding...
latest headlines for company on cafepharma
Yahoo/Fly on the Wall
Tue, 04/23/13 - 10:46 am
Motley Fool
Sat, 04/13/13 - 11:27 am
Motley Fool
Tue, 04/09/13 - 9:47 am
Reuters
Mon, 04/08/13 - 12:54 pm
Yahoo/Zacks
Wed, 02/27/13 - 12:33 pm
Motley Fool
Fri, 02/22/13 - 11:39 am
Seeking Alpha
Fri, 02/01/13 - 12:40 pm
Forbes
Wed, 01/30/13 - 11:36 am
Motley Fool
Mon, 01/28/13 - 1:25 pm
The Motley Fool
Sat, 01/19/13 - 1:12 pm
tags: Aegerion, Astra Zeneca, cancer, Isis Pharmaceuticals, treatment
Motley Fool
Sat, 01/12/13 - 11:47 am
Seeking Alpha
Sat, 01/12/13 - 11:44 am
Last 30 twitter posts
-
The Focus List for 5/24/13: Isis Pharmaceuticals and Health Management Associates top Friday's Focus List. Thi... t.co/vKD5nF6TpM
-
Isis <b>Pharmaceuticals</b> to Present at the Deutsche Bank 38th Annual dbAccess <b>...</b> t.co/0dPlkCpDVj
-
Isis Pharmaceuticals $ISIS Trading Near $21.94 Resistance Level ( t.co/vXrVIUIEN6 )
-
The Focus List for 5/23/13: Isis Pharmaceuticals and Amgen Inc top Thursday's Focus List. Think of the Focus L... t.co/rHDNKC3vmm
-
SDBN Feed: Isis Pharmaceuticals, Inc. to Present at the Deutsche Bank 38th Annual dbAccess… t.co/H4bx2PA45d
-
Isis Pharmaceuticals to Present at the Deutsche Bank 38th Annual dbAccess Health Care Conference t.co/JmCf8FuhPo
-
New post: Isis Pharmaceuticals to Present at the Deutsche Bank 38th Annual dbAccess Health Care Conference t.co/EbizudgBvh
-
Isis Pharmaceuticals to Present at the Deutsche Bank 38th Annual dbAccess Health Care Conference t.co/W0SiVFrHAx
-
Isis Pharmaceuticals to Present at the Deutsche Bank 38th Annual dbAccess Health Care Conference t.co/elualnSxKZ
-
$ISIS Isis Pharmaceuticals to Present at the Deutsche Bank 38th Annual dbAccess He.. t.co/YbSHv6uVVT
-
New market study, "Isis Pharmaceuticals, Inc. ... t.co/XpUE33KSGc
-
Isis states myotonic dystrophy drug entering clinic "later this year" t.co/RerTI7Q1HR #ISIS #MyotonicDotOrg
-
The Focus List for 5/21/13: Isis Pharmaceuticals and Alere Inc top Tuesday's Focus List. Think of the Focus Li... t.co/SVqUhUuTNs
-
Isis Pharmaceuticals' Management Presents at UBS Global Healthcare Conference Transcript t.co/lsRfnBxcZ2
-
Isis Pharmaceuticals' Management Presents at UBS Global Healthcare Conference (Transcript) t.co/xAIYIdglDZ
-
The Focus List for 5/20/13: Isis Pharmaceuticals and Alere Inc top Monday's Focus List. Think of the Focus Lis... t.co/g0BZjQb6vd
-
Isis <b>Pharmaceuticals</b> Inc (ISIS): Today's Most Compelling Stock Buy t.co/mvATjMN8ZC
-
ISIS <b>Pharmaceuticals</b> Stock Rating Upgraded by Zacks (ISIS) t.co/c6gmcbbqFp
Latest Health Message Board Posts
... . About Pharmasset Pharmasset is a clinical-stage pharmaceutical company committed to discovering, developing, and ... patients who received PSI-7977 in the same clinical trial. ISI Group analyst Mark Schoenebaum said the setback won't materially affect his ...
Posted by:
ActingBrandNew
at
2013-04-12 05:00:00
on
medhelp.org
... - 10:02 AM EDT WHITEHOUSE STATION, NJ (TheStreet) -- Vertex Pharmaceuticals(VRTX) defeats Merck(MRK) in the first battle of the hepatitis ... what telaprevir has demonstrated thus far," wrote ISI Group biotech analyst Mark Schoenebaum in an email to clients ...
Posted by:
andrey19
at
2013-02-15 06:00:00
on
medhelp.org
... Share on LinkedIn Share on Facebook Related NewsUPDATE 3-Isis-Genzyme cholesterol drug works; safety weighs Wed, Aug 4 2010 ... a separate trial of a rival drug being developed by Vertex Pharmaceuticals Inc (VRTX.O). "We have a compelling profile with ...
Posted by:
Nikodicreta
at
2013-01-04 06:00:00
on
medhelp.org
... Diagnostics, Scripps Clinic Liver Research Consortium, Siemens, Debio Pharmaceuticals, Intarcia, Intercept, Genentech, Isis Pharmaceuticals, Three Rivers Pharmaceuticals, and Peregrine Pharmaceuticals. Several authors were employees of Schering-Plough and ...
Posted by:
HectorSF
at
2011-12-17 06:00:00
on
medhelp.org
... (New York, NY), European Committee for Treatment and Research in MS, Eisai, INC Research, Eli Lilly Inc, Isis Pharmaceuticals Inc, MediciNova, Cleveland Clinic Foundation, Free University Amsterdam, Genentech/F. Hoffmann-LaRoche, Synthon BV, Antisense ...
Posted by:
nygirl7
at
2010-08-05 05:00:00
on
medhelp.org
... B after a challenge from generic drugmaker Teva Pharmaceutical Industries Ltd, Bristol-Myers said on Tuesday. "We are disappointed ... Teva officials could not immediately be reached for comment. ISI Group analyst Mark Schoenebaum said the U.S. Food and Drug ...
Posted by:
mikesimon
at
2010-08-04 05:00:00
on
medhelp.org
... of matter patent invalidated in a court fight with Teva Pharmaceutical Industries ($TEVA), which wants to sell its own version ... fraction of Baraclude's worldwide sales of $1.4 billion last year, and ISI Group analyst Mark Schoenebaum figures that a Teva ...
Posted by:
spectda
at
2010-07-13 05:00:00
on
medhelp.org